The popularity of Viagra initially fueled a surge for pharma, however recent shifts present a complicated picture for shareholders. Off-patent versions are eroding profits, and continued legal battles add additional https://alexiavyvn079046.blog-eye.com/41528573/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment